LATISSE® is an FDA-approved treatment designed to promote eyelash growth for individuals with inadequate or sparse lashes.
Interest in LATISSE® has surged since its introduction, and it’s easy to understand why. As the first FDA-approved prescription treatment for sparse eyelashes, LATISSE® is clinically proven to help lashes grow longer, fuller, and darker.
Book OnlineExperience The LATISSE® Difference.
LATISSE® is a treatment for hypotrichosis (insufficient or sparse eyelashes), and it stands as the first FDA-approved solution clinically shown to stimulate lash growth. As the first prescription-only lash growth product of its kind, a consultation with your doctor is required to determine if LATISSE® is suitable for you.
Eyes LATISSE® Helps Grow Lashes That Are Longer, Fuller, and Darker.
LATISSE® is a once-daily treatment applied to the base of your upper eyelashes, as directed by your doctor. Gradual results appear over time, with visible lengthening in as little as 4 weeks, and full lash growth typically achieved within 16 weeks. This is not an optical illusion—it’s genuine lash growth.
How LATISSE® Works.
LATISSE® promotes lash growth through its active ingredient, bimatoprost. While the exact mechanism is not fully understood, it’s believed that LATISSE® influences the anagen (growth) phase of the eyelash hair cycle in two ways: first, by extending the duration of this phase, and second, by increasing the number of hairs in the growth phase.
The History of LATISSE®.
LATISSE® was developed by Allergan. In 2001, the company created an eye drop to treat elevated intraocular pressure. Many patients using this treatment noticed an unexpected side effect: longer, fuller, and darker lashes. This led Allergan to investigate the effects of the active ingredient, bimatoprost, on eyelash growth. After conducting clinical trials, LATISSE® received FDA approval in December 2008.